Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluati 01. August 2014 http://www.ncbi.nlm.nih.gov/pubmed/25080228 Share